The most recent trading session ended with Enveric Biosciences, Inc. (ENVB) standing at $0.90, reflecting a -0.56% shift from the previouse trading day's closing. The stock trailed the S&P 500, which registered a daily gain of 1.02%. Elsewhere, the Dow saw an upswing of 0.4%, while the tech-heavy Nasdaq appreciated by 2.03%.Coming into today, shares of the company had lost 10% in the past month. In that same time, the Medical sector lost 5.2%, while the S&P 500 lost 3.15%.The investment community will be cl ...